Marek KL - Search Results

1

Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: a beta-CIT imaging study.

Seegal RF, Marek KL, Seibyl JP, Jennings DL, Molho ES, Higgins DS, Factor SA, Fitzgerald EF, Hills EA, Korrick SA, Wolff MS, Haase RF, Todd AC, Parsons P, McCaffrey RJ. Seegal RF, et al. Among authors: marek kl. Neurobiol Dis. 2010 May;38(2):219-25. doi: 10.1016/j.nbd.2010.01.009. Epub 2010 Jan 20. Neurobiol Dis. 2010. PMID: 20096358 Free PMC article.

2

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS, van Dyck C, et al. Seibyl JP, et al. Among authors: marek kl. Ann Neurol. 1995 Oct;38(4):589-98. doi: 10.1002/ana.410380407. Ann Neurol. 1995. PMID: 7574455

3

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

Marek KL, Seibyl JP, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Fussell B, Charney DS, van Dyck C, Hoffer PB, Innis RP. Marek KL, et al. Neurology. 1996 Jan;46(1):231-7. doi: 10.1212/wnl.46.1.231. Neurology. 1996. PMID: 8559382

4

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

Innis RB, Marek KL, Sheff K, Zoghbi S, Castronuovo J, Feigin A, Seibyl JP. Innis RB, et al. Among authors: marek kl. Mov Disord. 1999 May;14(3):436-42. doi: 10.1002/1531-8257(199905)14:3<436::aid-mds1008>3.0.co;2-j. Mov Disord. 1999. PMID: 10348466 Clinical Trial.

5

[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy.

Varrone A, Marek KL, Jennings D, Innis RB, Seibyl JP. Varrone A, et al. Among authors: marek kl. Mov Disord. 2001 Nov;16(6):1023-32. doi: 10.1002/mds.1256. Mov Disord. 2001. PMID: 11748733

6

The natural history of the syndrome of primary progressive freezing gait.

Factor SA, Jennings DL, Molho ES, Marek KL. Factor SA, et al. Among authors: marek kl. Arch Neurol. 2002 Nov;59(11):1778-83. doi: 10.1001/archneur.59.11.1778. Arch Neurol. 2002. PMID: 12433266

7

Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease.

Marek K, Jennings D, Seibyl J. Marek K, et al. Adv Neurol. 2003;91:183-91. Adv Neurol. 2003. PMID: 12442677 Review. No abstract available.

8

Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies.

Marek K, Jennings D, Seibyl J. Marek K, et al. Ann Neurol. 2003;53 Suppl 3:S160-6; discussion S166-9. doi: 10.1002/ana.10486. Ann Neurol. 2003. PMID: 12666107 Review. No abstract available.

9

Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopa.

Marek K, Jennings D, Seibyl J. Marek K, et al. Neurology. 2003 Sep 23;61(6 Suppl 3):S43-8. doi: 10.1212/wnl.61.6_suppl_3.s43. Neurology. 2003. PMID: 14504379 Review. No abstract available.

10

Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.

Shang Y, Gibbs MA, Marek GJ, Stiger T, Burstein AH, Marek K, Seibyl JP, Rogers JF. Shang Y, et al. J Clin Psychopharmacol. 2007 Feb;27(1):71-5. doi: 10.1097/JCP.0b013e31802e0017. J Clin Psychopharmacol. 2007. PMID: 17224717 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters